We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
21.7
quarters
Top 10 Avg Time Held
6.6
quarters
Top 20 Avg Time Held
9.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1676
Civista Bancshares
CIVB
$555M
| $31.2K | ﹤0.01% |
1,346
+1,015
| +307% | +$22.1K |
2025 Q1
1 quarter
|
|
1677
Invesco
IVZ
$12.9B
| $30.7K | ﹤0.01% |
1,948
-21
| -1% | -$302 |
2020 Q3
19 quarters
|
|
1678
Pelagos Insurance Capital
PLGO
$2.04B
| $30.2K | ﹤0.01% |
1,822
-1,056
| -37% | -$17.5K |
2024 Q1
5 quarters
|
|
1679
DELISTED
Verve Therapeutics
VERV
| $29.7K | ﹤0.01% |
2,645
+2,344
| +779% | +$13.4K |
2021 Q2
16 quarters
|
|
1680
Shinhan Financial Group
SHG
$35.3B
| $29.4K | ﹤0.01% |
651
| – | – |
2022 Q4
10 quarters
|
|
1681
DELISTED
Mr. Cooper
COOP
| $29.2K | ﹤0.01% |
196
-12,209
| -98% | -$1.57M |
2023 Q2
8 quarters
|
|
1682
Camden National
CAC
$947M
| $29.1K | ﹤0.01% |
718
-45
| -6% | -$1.76K |
2024 Q4
2 quarters
|
|
1683
HNI Corp
HNI
$3.41B
| $29.1K | ﹤0.01% |
591
| – | – |
2025 Q1
1 quarter
|
|
1684
APA Corp
APA
$16.4B
| $28.7K | ﹤0.01% |
1,570
-1,824
| -54% | -$31.6K |
2013 Q2
48 quarters
|
|
1685
Red Violet
RDVT
$1.29B
| $28.7K | ﹤0.01% |
583
+136
| +30% | +$5.93K |
2024 Q4
2 quarters
|
|
1686
Stitch Fix
SFIX
$361M
| $27.6K | ﹤0.01% |
7,454
-97,041
| -93% | -$363K |
2021 Q4
14 quarters
|
|
1687
Ericsson
ERIC
$30.5B
| $26.3K | ﹤0.01% |
3,096
-444
| -13% | -$3.65K |
2025 Q1
1 quarter
|
|
1688
Campbell Soup
CPB
$5.69B
| $26.2K | ﹤0.01% |
856
-2,785
| -76% | -$98K |
2019 Q1
25 quarters
|
|
1689
Kaltura
KLTR
$214M
| $25.9K | ﹤0.01% |
12,896
+5,044
| +64% | +$10.4K |
2024 Q4
2 quarters
|
|
1690
DELISTED
SkyWater Technology
SKYT
| $24.7K | ﹤0.01% |
+2,513
| New | +$20.3K |
2025 Q2
0 quarters
|
|
1691
Brown-Forman Class B
BF.B
$12.3B
| $24.7K | ﹤0.01% |
917
+792
| +634% | +$25.4K |
2025 Q1
1 quarter
|
|
1692
Cytek Biosciences
CTKB
$690M
| $24.6K | ﹤0.01% |
7,221
+4,343
| +151% | +$14.5K |
2023 Q4
6 quarters
|
|
1693
IBEX
IBEX
$594M
| $24.2K | ﹤0.01% |
830
| – | – |
2025 Q1
1 quarter
|
|
1694
Genie Energy
GNE
$444M
| $24.1K | ﹤0.01% |
897
| – | – |
2022 Q4
10 quarters
|
|
1695
Sanmina
SANM
$11.5B
| $24.1K | ﹤0.01% |
246
-295
| -55% | -$24.4K |
2013 Q2
48 quarters
|
|
1696
DELISTED
American Express Global Business Travel
GBTG
| $23.8K | ﹤0.01% |
3,776
| – | – |
2025 Q1
1 quarter
|
|
1697
Mohawk Industries
MHK
$7.95B
| $23.7K | ﹤0.01% |
226
-17
| -7% | -$1.77K |
2018 Q4
26 quarters
|
|
1698
Deluxe
DLX
$1.05B
| $23.3K | ﹤0.01% |
1,467
-1,318
| -47% | -$19.8K |
2013 Q2
48 quarters
|
|
1699
Xperi
XPER
$243M
| $22.8K | ﹤0.01% |
+2,885
| New | +$21.7K |
2025 Q2
0 quarters
|
|
1700
Intellia Therapeutics
NTLA
$1.76B
| $21.9K | ﹤0.01% |
2,336
-82
| -3% | -$673 |
2020 Q2
20 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.